Literature DB >> 18673373

The financial impact of immunosuppressant expenses on new kidney transplant recipients.

Elisa J Gordon1, Thomas R Prohaska, Ashwini R Sehgal.   

Abstract

BACKGROUND: This study aimed to examine kidney transplant recipients' ability to afford transplant-related out-of-pocket expenses and the financial impact of these expenses on their lives. PATIENTS AND METHODS: This cross-sectional study involved 77 kidney recipients. Variables analyzed were: ability to afford daily necessities; impact of immunosuppressant expenses on patients' lives; awareness of Medicare support terminating three yr post-transplant; and strategies used to pay for out-of-pocket transplant expenses. The Economic Strain Scale measured financial strain.
RESULTS: Twenty-nine percent of kidney recipients experienced financial strain. Poor, less educated, and younger patients were more likely to report financial strain. Out-of-pocket expenses relating to kidney transplantation adversely affected patients' ability to afford leisure activities (35%), a house (27%), and a car (26%). Thirty-one percent reported that immunosuppressant expenses have had somewhat to great (adverse) impact on their lives. Of those on Medicare and not disabled (n = 41), 51% were unaware Medicare coverage will terminate and 71% did not know how long coverage lasts.
CONCLUSIONS: Financial strain presents a considerable risk to kidney recipients' ability to purchase immunosuppression. Socioeconomic disparities in recipients' financial strain may be a source of disparities in graft survival. Transplant professionals should better inform transplant candidates about financial consequences of transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673373      PMCID: PMC2592494          DOI: 10.1111/j.1399-0012.2008.00869.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  33 in total

1.  Limiting long-term illness and the experience of financial strain in Sweden.

Authors:  Nelson Blank; Bo Burström
Journal:  Scand J Public Health       Date:  2002       Impact factor: 3.021

2.  Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants.

Authors:  R S Woodward; M A Schnitzler; J A Lowell; E L Spitznagel; D C Brennan
Journal:  Am J Transplant       Date:  2001-05       Impact factor: 8.086

3.  THE ETHICS OF MEDICARE POLICY: INCREASING TRANSPLANT ACCESS AND SURVIVAL.

Authors:  Elisa J Gordon
Journal:  De Paul Law Rev       Date:  2006

4.  Racial disparities in preferences and perceptions regarding organ donation.

Authors:  Laura A Siminoff; Christopher J Burant; Said A Ibrahim
Journal:  J Gen Intern Med       Date:  2006-09       Impact factor: 5.128

5.  Qualitative data analysis for health services research: developing taxonomy, themes, and theory.

Authors:  Elizabeth H Bradley; Leslie A Curry; Kelly J Devers
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

6.  Unequal access to cadaveric kidney transplantation in California based on insurance status.

Authors:  M Thamer; S C Henderson; N F Ray; C S Rinehart; J W Greer; G M Danovitch
Journal:  Health Serv Res       Date:  1999-10       Impact factor: 3.402

7.  The stress process.

Authors:  L I Pearlin; M A Lieberman; E G Menaghan; J T Mullan
Journal:  J Health Soc Behav       Date:  1981-12

Review 8.  Update in renal transplantation.

Authors:  Colm C Magee; Manuel Pascual
Journal:  Arch Intern Med       Date:  2004-07-12

9.  Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.

Authors:  D E Butkus; E F Meydrech; S S Raju
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

10.  The economics of kidney transplantation versus hemodialysis.

Authors:  P R Loubeau; J M Loubeau; R Jantzen
Journal:  Prog Transplant       Date:  2001-12       Impact factor: 1.065

View more
  14 in total

1.  Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.

Authors:  Matthew Kadatz; John S Gill; Jagbir Gill; Richard N Formica; Scott Klarenbach
Journal:  J Am Soc Nephrol       Date:  2019-11-08       Impact factor: 10.121

2.  Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.

Authors:  Margaret E Helmuth; Qian Liu; Marc N Turenne; Jeong M Park; Murewa Oguntimein; Sarah K Dutcher; Rajesh Balkrishnan; Pratima Sharma; Jarcy Zee; Alan B Leichtman; Abigail R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-28       Impact factor: 8.237

3.  The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes.

Authors:  Allyson Hart; Sally K Gustafson; Andrew Wey; Nicholas Salkowski; Jon J Snyder; Bertram L Kasiske; Ajay K Israni
Journal:  Am J Transplant       Date:  2019-03-05       Impact factor: 8.086

4.  Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA.

Authors:  Tadesse M Abegaz; Vakaramoko Diaby; Fatimah Sherbeny; Askal Ayalew Ali
Journal:  Clin Drug Investig       Date:  2022-05-25       Impact factor: 2.859

Review 5.  Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States.

Authors:  Bekir Tanriover; Patricia W Stone; Sumit Mohan; David J Cohen; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

6.  The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?

Authors:  Alexandra James; Roslyn B Mannon
Journal:  Curr Transplant Rep       Date:  2015-06-01

7.  The adoption of generic immunosuppressant medications in kidney, liver, and heart transplantation among recipients in Colorado or nationally with Medicare part D.

Authors:  Qian Liu; Abigail R Smith; Jeong M Park; Murewa Oguntimein; Sarah Dutcher; Ghalib Bello; Margaret Helmuth; Marc Turenne; Rajesh Balkrishnan; Melissa Fava; Charlotte A Beil; Adam Saulles; Sangeeta Goel; Pratima Sharma; Alan Leichtman; Jarcy Zee
Journal:  Am J Transplant       Date:  2018-03-31       Impact factor: 8.086

8.  Providers' View on the First Kidney Transplantation Center in Ethiopia: Experience From Past to Present.

Authors:  Tariku Shimels; Abrham Getachew; Mekdim Tadesse; Alison Thompson
Journal:  Health Serv Res Manag Epidemiol       Date:  2021-05-25

9.  Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study.

Authors:  Vanessa Grubbs; Laura C Plantinga; Eric Vittinghoff; Ann M O'Hare; R Adams Dudley
Journal:  BMC Health Serv Res       Date:  2012-08-16       Impact factor: 2.655

10.  How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study.

Authors:  Beverley M Essue; Germaine Wong; Jeremy Chapman; Qiang Li; Stephen Jan
Journal:  BMC Nephrol       Date:  2013-01-10       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.